Two Sigma Securities’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Two Sigma Securities's NVS Position: Q3 2025 in Review
Two Sigma Securities sold out of Novartis (NVS) in Q3 2025, closing a stake of 2,808 shares — an estimated $340K sold.
Two Sigma Securities first reported a position in NVS in Q1 2017 and held it in 17 quarters. The position peaked at $10.7M in Q1 2018. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.
- Two Sigma Securities reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
- Two Sigma Securities sold 2,808 Novartis shares in Q3 2025, an estimated $340K.
- Two Sigma Securities first reported a position in Novartis in Q1 2017 and held it in 17 quarters.
- Two Sigma Securities's Novartis position peaked at $10.7M in Q1 2018.
- 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.
Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.